Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 4;14(7):e26555.
doi: 10.7759/cureus.26555. eCollection 2022 Jul.

Incidental and Asymptomatic Splenic Infarction and Infrarenal Thrombus in a COVID-19 Patient

Affiliations
Case Reports

Incidental and Asymptomatic Splenic Infarction and Infrarenal Thrombus in a COVID-19 Patient

Jordan Childers et al. Cureus. .

Abstract

The cytokine storm associated with coronavirus disease 2019 (COVID-19) triggers a hypercoagulable state leading to venous and arterial thromboembolism. Lab findings associated with this phenomenon are elevated D-dimer, fibrinogen, C-reactive protein (CRP), ferritin, and procalcitonin. We present the case of a 66-year-old male with dyslipidemia who was diagnosed with COVID-19 with worsening shortness of breath, myalgia, and loss of taste. Physical examination was remarkable for crackles with diminished lung sounds and use of his accessory muscles. Labs showed normal white blood cell count, D-dimer of 1.42 mg/L, ferritin of 961 ng/mL, lactate dehydrogenase (LDH) of 621 U/L, and CRP of 2.1 mg/dL. Chest X-ray showed atypical pneumonitis with patchy abnormalities. He required oxygen supplementation with fraction of inspired oxygen of 100% proning as tolerated. He received remdesivir, ceftriaxone, azithromycin, dexamethasone, prophylactic enoxaparin, and a unit of plasma therapy. His D-dimer had increased from 1.65 to 3.51 mg/L with worsening dyspnea. At this time, computed tomography angiogram (CTA) of the chest showed extensive ground-glass opacities and a 2.4 × 1.9 × 1.3 cm distal thoracic aortic intraluminal thrombus. He was started on a heparin drip. A follow-up CTA of the aorta showed thrombus or hypoattenuation within the splenic artery and wedge-shaped areas extending from the hilum with possible infarction and a 6 mm thrombus in the infrarenal abdominal aorta. He was transitioned to enoxaparin 1 mg/kg twice daily. He remained asymptomatic from his splenic infarction. This case adds more insight to splenic infarction associated with COVID-19 in addition to the 32 reported cases documented thus far. Management of thromboembolism includes a therapeutic dose of anticoagulation. To prevent thromboembolism, prophylactic anticoagulation is recommended for those hospitalized with COVID-19.

Keywords: covid-19; hypercoagulable state; infrarenal thrombus; splenic infarction; splenic thrombus.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Computed tomography angiogram of the chest showing intraluminal thrombus in the distal thoracic aorta.
Figure 2
Figure 2. Computed tomography angiogram of the aorta showing thrombus within the splenic artery with wedge-shaped areas for possible infarction (arrowhead) and a 6 mm thrombus in the infrarenal abdominal aorta (arrow).
Figure 3
Figure 3. Computed tomography angiogram of the aorta showing hypoattenuation within the splenic artery for wedge-shaped areas around the hilum with possible infarction.

References

    1. COVID-19 infection and late manifestation of pulmonary aspergillosis. Bhopalwala H, Mishra V, Do TV, Gudipati M, Ganti SS. J Investig Med High Impact Case Rep. 2022;10:23247096211063332. - PMC - PubMed
    1. Splenic infarction in a postpartum patient with COVID-19. Mahmood SN, Dawod YT, Chan CM. TH Open. 2021;5:0–3. - PMC - PubMed
    1. Management of thrombotic complications in COVID-19: an update. Hajra A, Mathai SV, Ball S, et al. Drugs. 2020;80:1553–1562. - PMC - PubMed
    1. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Bikdeli B, Madhavan MV, Jimenez D, et al. J Am Coll Cardiol. 2020;75:2950–2973. - PMC - PubMed
    1. Unusual arterial thrombotic events in Covid-19 patients. de Roquetaillade C, Chousterman BG, Tomasoni D, et al. Int J Cardiol. 2021;323:281–284. - PMC - PubMed

Publication types

LinkOut - more resources